Encompass Health (EHC) Projected to Post Earnings on Thursday

Encompass Health (NYSE:EHC) is expected to be issuing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Encompass Health to post earnings of $1.29 per share and revenue of $1.5403 billion for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter in the prior year, the company posted $1.03 earnings per share. The firm’s revenue was up 9.4% on a year-over-year basis. On average, analysts expect Encompass Health to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Price Performance

Shares of EHC opened at $95.68 on Thursday. The stock has a market cap of $9.63 billion, a P/E ratio of 18.09, a price-to-earnings-growth ratio of 1.52 and a beta of 0.74. Encompass Health has a 1 year low of $92.53 and a 1 year high of $127.99. The stock’s 50-day moving average price is $106.81 and its two-hundred day moving average price is $115.14. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76.

Analysts Set New Price Targets

Several research firms recently weighed in on EHC. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Barclays boosted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. UBS Group raised their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Finally, Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $142.86.

Institutional Investors Weigh In On Encompass Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its position in Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after acquiring an additional 362 shares during the last quarter. Danske Bank A S acquired a new position in Encompass Health during the third quarter worth $76,000. Employees Retirement System of Texas grew its position in Encompass Health by 105.6% in the third quarter. Employees Retirement System of Texas now owns 956 shares of the company’s stock valued at $121,000 after purchasing an additional 491 shares in the last quarter. Headlands Technologies LLC increased its stake in Encompass Health by 5,474.1% in the 2nd quarter. Headlands Technologies LLC now owns 1,505 shares of the company’s stock valued at $185,000 after buying an additional 1,478 shares during the last quarter. Finally, Advisory Services Network LLC bought a new stake in Encompass Health during the 3rd quarter worth about $209,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.